Status:
COMPLETED
Electronic Symptom Monitoring Intervention for Hospitalized Patients With Cancer
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Alliance for Clinical Trials in Oncology Cancer Control Program (CCP)
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is evaluating a new way to deliver oncology care for patients with cancer
Detailed Description
Patients with cancer may experience a considerable symptom burden, often requiring hospitalizations for symptom management. The study doctors want to know if daily electronic monitoring of the symptom...
Eligibility Criteria
Inclusion
- Age 18 or older
- Diagnosed with advanced cancer (defined as receiving treatment with palliative intent as per chemotherapy order entry designation, oncology clinic notes, and/or trial consent forms, or not receiving chemotherapy but followed for incurable disease as per oncology clinic notes)
- Admitted to the oncology service at Massachusetts General Hospital
- Verbal fluency in English
Exclusion
- Unwilling or unable to participate in the study
- Admitted electively
- Participated during a previous admission
Key Trial Info
Start Date :
February 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2022
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT03396510
Start Date
February 12 2018
End Date
December 20 2022
Last Update
December 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114